Advanced search
Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Email Registration
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Germany
  4. Xetra
  5. Bayer AG
  6. News
  7. Summary
    BAYN   DE000BAY0017

BAYER AG

(BAYN)
  Report
Delayed Xetra  -  11:35 2022-09-29 am EDT
47.72 EUR   -0.98%
09/28Bayer CropScience Gets Board Nod to Sell Environmental Science Business for Nearly $14 Million
MT
09/27Sandoz Granted Leave To Add New Allegations On Condition Of Trial Adjournment And Extension Of 24-month Stay
AQ
09/27Santen Pharmaceutical Co., Ltd. - Ophthalmic VEGF inhibitor Eylea Solution for Intravitreal Injection 40 mg/mL obtains approval for ROP as sixth indication
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Most relevant news about BAYER AG
09/26Bayer Gets Japanese Regulatory Nod For Eye Drug in Preterm Infants
MT
09/20BAYER AG : Goldman Sachs maintains a Buy rating
MD
09/20BAYER AG : JP Morgan reaffirms its Buy rating
MD
09/15Bayer CEO says supply shortages cut crop protection sales in 2022
RE
09/15Transcript : Bayer Aktiengesellschaft - Special Call
CI
09/15BAYER AG : Bernstein gives a Buy rating
MD
09/13BAYER AG : Buy rating from Bernstein
MD
09/13Germany's Bayer Starts Looking for New CEO
MT
09/13Bayer Begins Search for CEO Werner Baumann's Successor, Bloomberg Reports
DJ
09/13BAYER AG : Bernstein reiterates its Buy rating
MD
09/09Bayer AG - Aflibercept 8 mg first to achieve extended injection intervals of 16 weeks i..
AQ
09/08Bayer-Regeneron Eye Drug Shows Effect at Higher Doses in Late-Stage Studies
MT
09/05Bayer - Kerendia receives updated label in the U.S. to include findings from Phase III ..
AQ
09/05BAYER AG : UBS remains its Buy rating
MD
09/05Germany's Bayer Enters $40 Million Settlement Deal Over Whistleblower Claims in US
MT
More most relevant news
All news about BAYER AG
09/28Bayer CropScience Gets Board Nod to Sell Environmental Science Business for Nearly $14 ..
MT
09/27Sandoz Granted Leave To Add New Allegations On Condition Of Trial Adjournment And Exten..
AQ
09/27Santen Pharmaceutical Co., Ltd. - Ophthalmic VEGF inhibitor Eylea Solution for Intravit..
AQ
09/26Australia's No. 2 telco Optus, government clash over massive data breach
RE
09/26U.S. farmers urge Washington to challenge Mexico's looming ban on GM corn
RE
09/26Bayer Gets Japanese Regulatory Nod For Eye Drug in Preterm Infants
MT
09/24Australia's Optus contacts customers caught in cyber attack
RE
09/22Australia's Optus says up to 10 million customers caught in cyber attack
RE
09/22Optus warns cyberattack may have exposed Australian client details
RE
09/21Singtel's Australian Unit Optus Hit by Cyberattack
DJ
More news
News in other languages on BAYER AG
09/28DAX-Chefs verdienen 24 Prozent mehr - Vergütungstransparenz sinkt
09/26Bayer obtient le feu vert des autorités japonaises pour un médicament oculaire destiné ..
09/26Bayer : traitement par Elyea autorisé au Japon
09/23Pvr : Bayer Aktiengesellschaft: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der e..
09/22Energia: Ahk Italien, supportare rinnovabili per favorire transizione green
09/22Pvr : Bayer Aktiengesellschaft: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der e..
09/22Optus prévient qu'une cyberattaque pourrait avoir exposé les coordonnées de clients aus..
09/20Le groupe Syngenta nomme Li Fanrong au poste de président du conseil d'administration
09/16Bayer Aktiengesellschaft : Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europa..
09/15Le PDG de Bayer affirme que les pénuries d'approvisionnement réduiront les ventes de pr..
More news
Analyst Recommendations on BAYER AG
09/20BAYER AG : Goldman Sachs maintains a Buy rating
MD
09/20BAYER AG : JP Morgan reaffirms its Buy rating
MD
09/15BAYER AG : Bernstein gives a Buy rating
MD
09/13BAYER AG : Buy rating from Bernstein
MD
09/13BAYER AG : Bernstein reiterates its Buy rating
MD
More recommendations
Press releases
09/27Sandoz Granted Leave To Add New Allegations On Condition Of Trial Adjournment And Exten..
AQ
09/27Santen Pharmaceutical Co., Ltd. - Ophthalmic VEGF inhibitor Eylea Solution for Intravit..
AQ
09/20Fitch Affirms Elanco's IDR at 'BB'; Outlooks Remains Negative
AQ
09/09Bayer AG - Aflibercept 8 mg first to achieve extended injection intervals of 16 weeks i..
AQ
09/05Bayer - Kerendia receives updated label in the U.S. to include findings from Phase III ..
AQ
More press releases
Analysis
Australia's Optus says up to 10 million customers caught in cyber attack
Official Publications
08/04Slide show half-year results 
08/04Half-year report 
08/04Half-year report 
05/101st quarter report 
05/101st quarter report 
04/29Shareholders meeting voting results 
Upcoming event on BAYER AG
11/08/22Q3 2022 Earnings Release
Upcoming sector events
10/18/22JOHNSON & JOHNSON : Q3 2022 Earnings Release
11/01/22PFIZER INC. : Q3 2022 Earnings Release
11/01/22ELI LILLY AND COMPANY : Q3 2022 Earnings Release
11/04/22ABBVIE INC. : Q3 2022 Earnings Release (Projected)
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Other Pharmaceuticals